Chemours published its 2025 annual report, outlining progress under its Pathway to Thrive strategy across operational execution, growth initiatives, portfolio actions, and legacy liability resolution. The company said its Thermal & Specialized Solutions business saw Opteon refrigerants net sales rise 56% year over year as adoption increased under global regulation. Chemours reported commercialization steps for its two-phase liquid cooling solution, including technical qualification by Samsung Electronics and a trial with NTT Data, along with a manufacturing agreement with Navin Fluorine. Portfolio actions included an announced exit of the SPS Capstone business at the Villers-St. Paul site in France and consolidation of Viton fluoroelastomers manufacturing at Chambers Works. Chemours also cited a proposed judicial consent order to resolve pending environmental and other litigation claims by the State of New Jersey.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Chemours Company published the original content used to generate this news brief on March 11, 2026, and is solely responsible for the information contained therein.
Comments